Mirae Asset Celltrion Growth Fund
Scope
Date
~
-
IPOs
Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut
SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...
Jan 16, 2025 (Gmt+09:00)
-
Cryptocurrencies
Korea seeks tighter control over digital coins, mulls mandatory disclosures
South Korea plans to tighten its controls over cryptocurrency trade in the country by mandating information disclosures for listed virtual assets an...
Jan 15, 2025 (Gmt+09:00)
-
Economy
S.Korea’s job growth slows for 2nd straight year in 2024
South Korea’s job growth slowed last year amid a prolonged slump in the country’s construction, manufacturing and retail sectors, boding...
Jan 15, 2025 (Gmt+09:00)
-
Regulations
Korea seeks to ease fintech ownership, crypto regulations
South Korea’s top financial regulator has proposed loosening restrictions on financial holding companies’ ownership of fintech platforms...
Jan 09, 2025 (Gmt+09:00)
-
Corporate investment
Mirae Asset invests $200 mn in LS Group affiliate in US
South Korea's Mirae Asset Global Investments said on Sunday it invested $200 million in Essex Solutions, a US magnet wire manufacturing affiliate un...
Jan 06, 2025 (Gmt+09:00)
-
Shareholder activism
Korean activist investors to routinize campaigns throughout year
South Korea’s activist investors are set to routinize campaigns all year long rather than launch fresh moves only before annual general meetin...
Jan 03, 2025 (Gmt+09:00)
-
Foreign exchange
NPS initiates strategic currency hedging to unleash up to $48.2 billion
The National Pension Service (NPS), South Korea’s state-run pension fund and the country’s largest institutional investor, is set to beg...
Jan 03, 2025 (Gmt+09:00)
-
Business & Politics
Korea sharply cuts 2025 growth forecast, opens door for extra budget
South Korea sharply lowered its economic growth forecast for this year amid the prolonged political turmoil following President Yoon Suk Yeol’...
Jan 02, 2025 (Gmt+09:00)
-
Bio & Pharma
Korean drugmakers control more than half of European biosimilar market
South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...
Jan 02, 2025 (Gmt+09:00)
-
Alternative investments
Korean pension funds raise bets on infrastructure, global stocks
South Korean pension funds are raising their bets on infrastructure and global stocks, while reducing exposure to the domestic stock market on a dow...
Jan 01, 2025 (Gmt+09:00)
-
Korean startups
Imagoworks raises $15.6 mn in Series C funding
Imagoworks, South Korea's AI-based digital dental service startup, said on Tuesday it raised 23 billion won ($15.6 million) in Series C funding.Foun...
Dec 31, 2024 (Gmt+09:00)
-
Foreign exchange
Korea to relax FX rules by December to boost dollar selling
South Korea will raise the limits on forward dollar purchases and expand the foreign exchange swap line between the National Pension Service (NPS) a...
Dec 23, 2024 (Gmt+09:00)
-
Real estate
GIC drops Seoul landmark building sale on Korea’s political woes
Singapore’s GIC Private Ltd., the world’s sixth-largest sovereign wealth fund, dropped the sale of a landmark building in Seoul due to t...
Dec 19, 2024 (Gmt+09:00)
-
Debt financing
POSCO to raise up to $691 million as next year’s 1st corporate bond issuer
South Korea’s steel-to-battery materials conglomerate POSCO Group plans to raise up to 1 trillion won ($691 million) in the country’s fi...
Dec 19, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion obtains approval of Steqeyma from FDA
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
Dec 18, 2024 (Gmt+09:00)
-
Pension funds
NPS to invest record $1.4 billion in Korean property market in 2025
South Korea’s National Pension Service (NPS) plans to invest 2 trillion won ($1.4 billion) in the domestic real estate market next year to gai...
Dec 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion BioSolutions launched to venture into CDMO
Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...
Dec 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s 4 new biosimilars win EU approval recommendation
Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...
Dec 16, 2024 (Gmt+09:00)
-
Korean startups
CLO Virtual Fashion raises $35 mn
South Korea's 3D digital fashion solution startup CLO Virtual Fashion said on Monday it raised 50 billion won ($35 million).Atinum Investment Co. an...
Dec 16, 2024 (Gmt+09:00)
-
Markets
Celltrion to allot cash, stock dividend at once
South Korea’s biosimilar maker Celltrion Inc. on Friday announced a plan to allot cash and stock dividends simultaneously. The company wi...
Dec 13, 2024 (Gmt+09:00)
-
Korean startups
Language learning app Speakeasy joins ranks of unicorn startups
Speakeasy Labs Inc., a South Korea-focused language learning app operator, has joined the ranks of unicorn startups after raising $78 million at a v...
Dec 12, 2024 (Gmt+09:00)
-
Asset management
Mirae Asset rises to 12th-largest ETF manager with $141 billion in assets
South Korea’s leading asset manager Mirae Asset Financial Group has emerged as the world’s 12th-largest exchange-traded fund (ETF) manag...
Dec 11, 2024 (Gmt+09:00)
-
Real estate
GIC to open 2nd tender for Seoul landmark building sale as bids disappoint
Singapore’s GIC Private Ltd., the world’s sixth-largest sovereign wealth fund, is set to seek more proposals from bidders to sell a land...
Dec 11, 2024 (Gmt+09:00)
-
Capital raising
Korean firms halt bond, share issues despite tighter liquidity
South Korean companies are postponing bond issues and initial public offerings on chilled investor sentiment in the aftermath of President Yoon Suk ...
Dec 11, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
LX Pantos IPO delayed as Mirae Asset sells stake
South Korea’s leading brokerage firm Mirae Asset Securities Co. is poised to sell its stake in LX Pantos Co., adding to expectations of more d...
Dec 09, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Dec 09, 2024 (Gmt+09:00)
-
Business & Politics
S.Korea's Yoon survives impeachment; economic fundamentals firm
South Korean President Yoon Suk Yeol survived an impeachment vote against him after an overwhelming majority of governing party lawmakers boycotted ...
Dec 07, 2024 (Gmt+09:00)
-
Corporate investment
Samsung invests in AI security platform Axiado
Samsung Electronics Co. said on Thursday it invested in the Series C funding round of Axiado, a US-based artificial intelligence (AI) security platf...
Dec 05, 2024 (Gmt+09:00)
-
Economy
S.Korea's foreign reserves amount to $415.4 bn in Nov
South Korea's official foreign reserves at the end of November amounted to $415.4 billion.According to the Bank Of Korea (BOK) on Wednesday, the nat...
Dec 04, 2024 (Gmt+09:00)
-
Shareholder value
Celltrion to retire $400 mn treasury stock in January
South Korea’s biosimilar maker Celltrion Inc. on Wednesday announced a plan to retire about a quarter of its treasury stock worth 563 billion ...
Dec 04, 2024 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand